Navigation Links
Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
Date:7/10/2013

San Francisco, CA (PRWEB) July 10, 2013

The user experience of technical software is often disappointing, frequently reflecting more how it’s made than how it’s used. Medrio 8.1 presents a new user interface that is workflow-driven and faster for users. “By observing how both new and experienced researchers do their work, it became clear that there were separate data entry and monitoring workflows which are rarely done at the same time,” said Jeff Johnson, Medrio’s Director of Customer Experience.

Data Entry users need to enroll patients, see what data is scheduled to be entered at the present moment, and respond to queries. Data Monitors, on the other hand, need to see what data needs cleaning, close queries and monitor forms. Each of these workflows can be streamlined. The new 8.1 Medrio user interface is faster, requires fewer clicks to complete common tasks, and is more aesthetically pleasing.

“Additionally, Medrio 8.1 introduces fully validated and 21 CFR part 11 compliant data entry via iPad,” said Michael Farr, Medrio's Manager of Medrio's Scholars. “Although Medrio is not available without charge for commercial studies requiring 21 CFR part 11 compliance, we’ve found that many of our University customers do both academic and commercially sponsored studies and like being able to use one EDC for both. Getting a study database is as simple as visiting scholars.medrio.com and entering an email address."

"Our research program has been using Medrio for less than a year, but has come to rely on the system for a legion of functionality we simply can't get in REDCap. From the forms which can easily be created or copied from our other studies to monitoring, reporting and approval processes; all accessible from any computer using a standard web browser, Medrio is a very comprehensive solution. Additionally, given their support and responsiveness it's astounding they are free," said Troy Hamilton, Clinical Research Manager Division of Nephrology at the University of Calgary.

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Medrio is available free for investigator initiated studies that are university and/or government funded. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit scholars.medrio.com to learn more about Medrio’s Scholars program.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/SaaS/prweb10823158.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
2. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
3. Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes
4. Metabolix Executives to Present at Leading Industry Conferences
5. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
6. Alexandrias 499 Illinois Street in Mission Bay, San Francisco, Signs Anchor 97,700 Rentable Square Foot Lease with Leading Mid-Cap Life Science Company
7. Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013
8. Safe Non-Toxic Enzyme Cleaner Replaces Bleach as Leading Mold & Flood Cleaning Solution
9. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
10. Tata Partners with Tel Aviv University to Fund Leading Edge Innovations for Accelerated Commercialization
11. PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... ... ... a basic first aid supply for any work environment, but most personal eye wash can ... a dangerous substance enters both eyes? It’s one less decision, and likely quicker response time ... , “Whether its dirt and debris, or an acid or alkali, getting anything in your ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):